Head circumference at 12 months (z scores) ‐ DHA and AA vs normal term formula · term infants
LCPUFA supplemented formula showed no clear difference in head circumference at 12 months (z scores) ‐ DHA and AA vs normal… compared with control formula (low certainty).
1 finding from 1 review
Coronary events (MI or cardiac death) · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher coronary events (MI or cardiac death) compared with placebo (moderate certainty).
1 finding from 1 review
Venous thromboembolism · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) probably leads to higher venous thromboembolism (DVT or PE) compared with placebo (moderate certainty).
1 finding from 1 review
Venous thrombo‐embolism (DVT or PE): CEE 0.625 mg (moderate dose) · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) showed no clear difference in venous thromboembolism (DVT or PE): CEE 0.625 mg (moderate dose) compared with placebo (moderate certainty).
1 finding from 1 review
Breast cancer · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) showed no clear difference in breast cancer compared with placebo (moderate certainty).
1 finding from 1 review
Gallbladder disease · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) probably leads to higher gallbladder disease compared with placebo (moderate certainty).
1 finding from 1 review
All clinical fractures · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) probably leads to lower all clinical fractures compared with placebo (moderate certainty).
1 finding from 1 review
Stroke · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher stroke compared with placebo (moderate certainty).
1 finding from 1 review
Venous thromboembolism · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher venous thromboembolism (DVT or PE) compared with placebo (moderate certainty).
1 finding from 1 review
Breast cancer · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher breast cancer compared with placebo (moderate certainty).
1 finding from 1 review
Mortality: lung cancer · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher death from lung cancer compared with placebo (moderate certainty).
1 finding from 1 review
Gallbladder disease · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher gallbladder disease compared with placebo (moderate certainty).
1 finding from 1 review
All clinical fractures · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to lower all clinical fractures compared with placebo (moderate certainty).
1 finding from 1 review
Coronary events (MI or cardiac death) · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) showed no clear difference in coronary events (MI or cardiac death) compared with placebo (moderate certainty).
1 finding from 1 review
Stroke · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) probably leads to higher stroke compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Clinical outcomes: physical heath · adults with chronic conditions
1 finding from 1 review
Intervention not reported
Clinical outcomes: mental health · adults with chronic conditions
1 finding from 1 review
Intervention not reported
Patient‐reported outcome measures (PROMs) · adults with chronic conditions
1 finding from 1 review
Intervention not reported
Hospital admissions · adults with chronic conditions
1 finding from 1 review
Intervention not reported
Process of care · adults with chronic conditions
1 finding from 1 review